Congress objectives The EHA Annual Congress is a forum for original unpublished data, sharing ideas about hematological innovation, as well as for disseminating evidence-based knowledge of primary clinical relevance. Hematologists and affiliated professionals will be able to: Enhance their knowledge of evidence-based approaches to diagnosis and treatment for hematologic diseases. Access the latest results on clinical and translational research in hematologic disorders. Be updated on emerging innovative techniques, diagnostic tools and risk-assessment strategies in hematology and its subspecialties. Communicate, collaborate and network with representatives of a large international audience – medical professionals, national hematology societies, patient groups, medical industry and the media.